Work

Liraglutide-Induced Liver Injury: A Case Report and Review

Year: 2025

Type: article

Abstract: Introduction: Glucagon-like peptide-1 receptor agonists such as liraglutide have revolutionized the management of type 2 diabetes and obesity. Case Presentation: We present a case of a 30-year-old woman who developed drug-induced liver injury (DILI) to liraglutide, confirmed on histology, with resolution on cessation of liraglutide over 6 months. Conclusion: DILI secondary to liraglutide appears to be a rare but an important adverse effect.

Source: Case Reports in Gastroenterology

DOI: 10.1159/000547634

Authors: Mark Lai, Patrick Hosking, Rohit Sawhney, Amanda Nicoll

Institutions: Eastern Health, Monash University

Language: English

Topic: Drug-Induced Hepatotoxicity and Protection

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,030